First Patients Vaccinated in Clinical Trial of Experimental HIV Vaccine

Dr. David Diemert, director of The GW Vaccine Research Unit, was interviewed on CTV Your Morning about our current clinical trial of an experimental HIV vaccine.

“The future implications are huge if we could have an effective HIV vaccine that would prevent people from getting the infection and thereby not having to go on antiretroviral medication for the rest of their lives,” he says.

Latest News

FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV
Mpox Vaccine Is Safe and Generates a Robust Antibody Response in Adolescents
Latest news about the results of the COVAIL trial regarding the Sanofi booster. GW participated as one of the many sites for this COVID-19 vaccine study.